Literature DB >> 9253257

Regulating the pharmaceutical industry.

A Maynard, K Bloor.   

Abstract

Mesh:

Year:  1997        PMID: 9253257      PMCID: PMC2127150          DOI: 10.1136/bmj.315.7102.200

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  8 in total

1.  Ethics and health care 'underfunding'.

Authors:  A Maynard
Journal:  J Med Ethics       Date:  2001-08       Impact factor: 2.903

2.  The need for pharmacoeconomic evaluations in the NHS.

Authors:  J P Griffin
Journal:  Pharmacoeconomics       Date:  1998-09       Impact factor: 4.981

3.  Challenges for the National Institute for Clinical Excellence.

Authors:  Alan Maynard; Karen Bloor; Nick Freemantle
Journal:  BMJ       Date:  2004-07-24

4.  Quality control in the regulation of pharmaceuticals.

Authors:  Alan Maynard
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

5.  Prescription charges: change overdue? Britain can learn from systems of copayments based on drugs' effectiveness.

Authors:  T Walley
Journal:  BMJ       Date:  1998-08-22

Review 6.  Customising an international disease management model to the needs of individual countries. Application to upper gastrointestinal disease.

Authors:  A Haycox; D Dubois; M Butterworth
Journal:  Pharmacoeconomics       Date:  1998       Impact factor: 4.981

7.  Rationing treatment on the NHS--still a political issue.

Authors:  Elias Mossialos; Martin McKee
Journal:  J R Soc Med       Date:  2003-08       Impact factor: 18.000

8.  Where to go with new expensive treatments in NSCLC.

Authors:  A Webb; M E O'Brien
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.